Navigation Links
Significantly Higher Percentage of Hetastarch Recipients Underwent a Surgical Procedure Than Those Receiving Albumin/Plasma Protein Fraction
Date:9/17/2009

MALVERN, Pa., Sept. 17 /PRNewswire/ -- Arlington Medical Resources (AMR), a provider of premier market intelligence for the pharmaceutical and diagnostic imaging industries, finds that for the January - May 2009 time period, a significantly higher percentage of hetastarch recipients (75%) underwent a surgical procedure when compared to those receiving albumin/plasma protein fraction (51%). Hetastarch, albumin and plasma protein fraction are plasma expanders that are mainly used in hospital patients to replace fluid in cases of severe shock, as may occur with blood or fluid loss during surgery.

The newly released U.S. edition of the Plasma Expander Hospital Inpatient Profile Study also finds that albumin 25% is most often administered to patients with liver disease and hypotension/shock due to infection or surgical blood loss. Similarly, albumin and plasma protein fraction 5% are most often administered to patients with hypotension/shock from surgical blood loss, cardiogenic hypotension/shock and cardiopulmonary bypass procedures.

AMR's new Plasma Expander Hospital Inpatient Profile Study clinically characterizes U.S. hospital inpatient recipients of plasma expanders such as albumin, plasma protein fraction and hetastarch to identify relative usage patterns by indication, patient age and sex, prescribing physician specialty, dosing and primary method of payment.

"The new Plasma Expander Hospital Inpatient Profile Study is a nice complementary study to our Plasma Expander Hospital Purchasing Audit," stated Mary Walker, R.Ph., MBA, therapeutics principal director at AMR. "While the Purchasing Audit enables pharmaceutical companies to monitor the market size, market potential or market influences of plasma expanders, the Inpatient Profile Study allows these same companies to monitor plasma expander users and prescribers."

Why Pharmaceutical Companies Need this Information

The Plasma Expander Hospital Inpatient Profile Study enables pharmaceutical companies to monitor patient shares, prescribing physician specialty, dosing and payment method of plasma expander use in the hospital setting.

About AMR

AMR (www.AMR-data.com) serves the market intelligence needs of the pharmaceutical and diagnostic imaging industries. Research includes clinical inpatient databases that directly link anti-infective drug with indication/procedure, formulary and stocking status tracking studies, drug purchasing audits and diagnostic imaging procedure volume/contrast media usage audits. AMR is a Decision Resources, Inc. company.

About Decision Resources, Inc.

Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

For more information, contact:

    Gisselle Morales                             Elizabeth Marshall
    Decision Resources                           Decision Resources, Inc.
    781-296-2691                                 781-296-2563
    gmorales@dresources.com                      emarshall@dresources.com


'/>"/>
SOURCE Arlington Medical Resources
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. New Data Show ChloraPrep(R) Significantly More Effective Than DuraPrep(TM) and Povidone-Iodine in Eliminating Bacteria From Skin Prior to Shoulder Surgery
2. HealthWarehouse.com, Inc. Announces Second Quarter Financial Results; Revenues Increase Significantly Over Second Quarter 2008
3. Iterative reconstruction technique significantly reduces patient radiation dose during CT scans
4. Cord Blood America Says Balance Sheet Significantly Strengthened in 2009
5. Heavy drinkers face significantly increased cancer risk
6. Rate of Breast Cancer in Italy Significantly Higher Than Previously Reported
7. Hospital for Special Surgery is Only New York Hospital with Significantly Lower Surgical Site Infection Rate for Hip Replacement Compared to State Average
8. The Latin American Digital Radiography Market to Grow Significantly due to the Need to Improve Digital Adoption, Observes Frost & Sullivan
9. Published Study Shows VNUS ClosureFAST™ System Significantly Superior to Laser for Varicose Vein Treatment
10. Botox injections can significantly improve quality of life for people with overactive bladders
11. VIVUS Qnexa Shows Significantly Improved Blood Sugar Control Through Weight Loss In Patients With Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... ... January 24, 2017 , ... “The Octagon of Spiritual Balances”: ... of Spiritual Balances” is the creation of published author, Pastor Bernard J. Weathers, pastor ... holds a bachelor degree in religious education and a master degree in theology. , ...
(Date:1/24/2017)... ... 23, 2017 , ... OSF Ventures, the corporate investment arm ... platform headquartered in Silicon Valley that connects startups to corporations and invests in ... three-year agreement to be a corporate sponsor of Plug and Play’s program for ...
(Date:1/24/2017)... ... January 23, 2017 , ... During the ... Carol Francis, Psychologist in the South Bay area , explained “Watching Women’s ... all people and by all people shines as a bright beacon of determination ...
(Date:1/23/2017)... , ... January 23, 2017 ... ... translation and localization services for life science companies, has achieved ISO 17100:2015 ... TÜV SÜD America. ISO 17100 is the globally recognized standard that establishes ...
(Date:1/23/2017)... ... January 23, 2017 , ... The Masters ... management and evaluation leaders with decades of experience who remain current practitioners in ... States healthcare system, there is a renewed demand for versatile, data-driven leadership.The American ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... Jan. 23, 2017 Laboratory Markets Limited has ... of mass spectrometry in both clinical and research laboratory ... global market size of $6.8 billion and growing to ... years, profiles the use of mass spectrometry across more ... This study investigated growth in the use of mass ...
(Date:1/23/2017)... 23, 2017 The Pharmacy Technician Certification ... of the planned 2020 accredited education requirement for ... announced in 2013 that the requirement would take ... map of program changes designed to keep pace ... pharmacy. "We have determined that ...
(Date:1/23/2017)... 23, 2017  Based on its recent analysis ... recognizes Ansell, a global leader in protection solutions, ... of the Year Award. Ansell,s comprehensive product portfolio, ... global footprint have placed it in a position ... The Company,s established product line and robust innovation ...
Breaking Medicine Technology: